Alnylam Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	-319.09	-278.16	-440.24	-1,131	-852.82	-858.28	Upgrade
Depreciation & Amortization	56.5	56.67	54.05	44.47	89.69	74.44	Upgrade
Loss (Gain) From Sale of Investments	4.04	3.02	16.94	33.31	-55.7	-54.04	Upgrade
Stock-Based Compensation	305.84	272.08	221.68	230.65	165.72	139.87	Upgrade
Other Operating Activities	171.41	152.15	194.46	273.84	174.24	95.76	Upgrade
Change in Accounts Receivable	-240.95	-86.55	-87.94	-45.6	-101.8	-56.24	Upgrade
Change in Inventory	24.13	13.59	18.37	-34.14	-26.42	-35.43	Upgrade
Change in Accounts Payable	47.9	91.09	80.84	191.77	88.24	143.73	Upgrade
Change in Unearned Revenue	-56.34	-235.45	55.02	-65.91	-50.4	-43.97	Upgrade
Change in Other Net Operating Assets	-8.99	3.23	-9.03	-38.51	-72.45	-20.81	Upgrade
Operating Cash Flow	-15.54	-8.31	104.16	-541.27	-641.69	-614.96	Upgrade
Capital Expenditures	-36.55	-34.28	-62.21	-72.06	-76.37	-70.36	Upgrade
Investment in Securities	-54.91	-63.25	-269.7	254.61	-192.56	-333.96	Upgrade
Other Investing Activities	-19.32	-19.32	-4.44	-13.19	-4.36	-31.2	Upgrade
Investing Cash Flow	-110.77	-116.84	-336.35	169.35	-273.3	-435.52	Upgrade
Long-Term Debt Issued	-	-	-	1,016	500	200	Upgrade
Long-Term Debt Repaid	-	-	-	-880.72	-	-	Upgrade
Net Debt Issued (Repaid)	-	-	-	135.39	500	200	Upgrade
Issuance of Common Stock	274.9	302.95	147.46	259.36	246.27	299.98	Upgrade
Other Financing Activities	-43.31	-8.79	24.67	31	500.85	495	Upgrade
Financing Cash Flow	231.59	294.16	172.13	425.75	1,247	994.98	Upgrade
Foreign Exchange Rate Adjustments	39.39	-15.24	6.39	-7.43	-9.02	4.92	Upgrade
Net Cash Flow	144.67	153.77	-53.67	46.4	323.11	-50.58	Upgrade
Free Cash Flow	-52.09	-42.59	41.95	-613.33	-718.07	-685.32	Upgrade
Free Cash Flow Margin	-2.12%	-1.89%	2.29%	-59.12%	-85.05%	-139.05%	Upgrade
Free Cash Flow Per Share	-0.40	-0.33	0.34	-5.04	-6.06	-5.96	Upgrade
Cash Interest Paid	109.97	67.58	32.12	45.24	24.66	-	Upgrade
Cash Income Tax Paid	11.9	14.36	6.02	2.65	-	-	Upgrade
Levered Free Cash Flow	85.71	197.88	103.55	-444.35	97.11	-777.14	Upgrade
Unlevered Free Cash Flow	180.86	286.54	179.32	-346.87	186.5	-724.33	Upgrade
Change in Working Capital	-234.24	-214.08	57.26	7.62	-162.82	-12.7	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.